References
- Ahlstedt S. The antibacterial effects of low concentra-tions of antibiotics and host defence factors: a review. J Antimicrob Chemother 1981; 8 (Suppl.C): 59-70.
- Dutcher BS, Reynard AM, Beck ME, Cunningham RK. Potentiation of antibiotic bactericidal activity by normal human serum. Antimicrob Agents Chemother 1978; 13 (5): 820–6.
- Fietta A, Mangiarotti P, Gialdroni Grassi G. Effects of antibiotics on the bactericidal activity of human serum. J Antimicrob Chemother 1982; 9: 141–8.
- Miglioli PA, Pea F, Zatti V. Enhancement of in vitro activity of ofloxacin and gentamicin by rat serum. J Chemother 1990; 2 (6): 368–70.
- Miglioli PA, Schoeffel U, Gianfranceschi L. The in vitro synergistic inhibitory effect of human amniotic fluid and gen-tamicin on growth of Escherichia coli. Chemotherapy 1996; 42: 206–9.
- Miglioli PA, Allerberger F, Walderberg I, Hasse J. Antibacterial activity of human pleural fluid: alone and in com-bination with antibiotics. Int J Antimicrob Agents 1998; 10: 317–9.
- Miglioli PA, Schoeffel U, Gabroska E, Allerberger F. Antibacterial activity of peritoneal exudate in patients treated with 2 g cefotiam for surgical antimicrobial prophylaxis. Chemotherapy 1998; 44: 149–52.
- Miglioli PA, Bertazzoni-Minelli E, Berti T. Enhancement of antibiotic antibacterial activity by experimental pleural exu-dates. Drugs Exp Clin Res 1987; 13 (3): 161–6.
- Fromkes JJ, Thomas FB, Mekhjian HS, Evavns M. Antimicrobial activity of human ascitic fluid. Gastroenterology 1977; 73: 668–72.
- Simberkoff MS, Moldover NH, Weiss G. Bactericidal and opsonic activity of cirrhotic ascites and nonascitic peri-toneal fluid. J Lab Clin Med 1978; 91 (5): 831–9.
- Runyon BA, Antillon MR, McHutchison JG. Diuresis increases ascitic fluid opsonic activity in patients who survive spontaneous bacterial peritonitis. J Hepatol 1992; 14(2-3): 249–52.
- Fromkes JJ, Thomas FB, Kraut EH. Activation of the alternative complement pathway in ascitic fluid during sponta-neous bacterial peritonitis. J Clin Gastroenterol 1982, 4 (4): 347–50.
- Akalin HE, Laleli Y, Telatar H. Bactericidal and opson-ic activity of ascitic fluid from cirrhotic and noncirrhotic patients. J Infect Dis 1983; 147 (6): 1011–7.
- National Committee for Clinical Laboratory Standard. Method for dilution antimicrobial susceptibility for bacteria that growth aerobically. 4th ed. Approved standard. Publication n°M7-A4,1997.
- National Committee for Clinical Laboratory Standard. Performance Standards for antimicrobial susceptibility testing. (8 th International supplement Approval standard. Publication n°M 100-S8. 1998.
- Eliopoulos GM, Moellering RG. Antimicrobial combina-tions. In: Antibiotics in laboratory medicine. Lorian V, ed. 4th ed. Baltimore: Williams and Wilkins, 1996: 330-96.
- Taylor PW. Bactericidal and bacteriolitic activity of serum against Gram-negative bacteria. In: Microbiol Rev. American Society for Microbiology, 1983; 47 (1): 46–83.
- Bladen HA, Gewurtz H, Mergenhangen SE. Interaction of the C system with the surface and endotoxic lypopolisac-charide of Veilonella alcalescens. J Expt Med 1967; 125; 767.
- Feingold DS, Goldman JN, Kuritz HM. Focus on the action of serum and the role of lysozyme in the serum bacteri-cidal reaction. J Bacteriol 1968; 96: 2118–36.
- Hermsen ED, Hovde LB, Sprandel KA, Rodvold KA, Rotschafer JC. Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model. Antimicrob Agents Chemother 2005; 2: 685–9.
- Fernandez J, Bauer TM, Navasa M, Rodes J. Diagnosis, treatment and prevention of spontaneous bacterial peritonitis. Baillieres Best Pract Res gastroenterol 2000; 14 (6): 975–990.